| Parent Drug Name | Name of Impurity | Catalogue No. | |
|---|---|---|---|
| Risedronic acid | Risedronic acid | VL3780001 | View CAS 105462-24-6 |
Risedronic Impurities
| Parent Drug Name | Name of Impurity | Catalogue No. | |
|---|---|---|---|
| Risedronic acid | Risedronic acid | VL3780001 | View CAS 105462-24-6 |
[rfq_list]
| Catalogue No. | VL3780001 |
| CAS No. | 105462-24-6 |
| Molecular Formula | C7H11NO7P2 |
| Molecular Weight | 283.11 |
| Parent drug | Risedronic acid |
| IUPAC Name | 1-Hydroxy-2-(3-pyridyl)-ethan-1, 1-bis-phosphonic acid |
| Synonyms | Risedronate |
| References | “Sci-Hub, Alendronic Acid Produces Greater Effects than Risedronic Acid on Bone Density and Turnover in Postmenopausal Women with Osteoporosis, 10.2165/00044011-200626020-00002.” Hkvisa.net, 2022, sci-hub.hkvisa.net/10.2165/00044011-200626020-00002. |
| Status | Not Available |
| ListName | Risedronic acid |
| Exclusively Supplied by Veeprho | Exclusively Supplied by Veeprho |
"*" indicates required fields
